Fine-Tuning Psoriasis Care: Reflecting on patient needs and treatment choices to optimize care


Melinda Gooderham, MD, MSc, FRCPC
Dermatologist, Skin Centre for Dermatology
Assistant Professor, Queen’s University
Investigator, Probity Medical Research
Peterborough, ON

Perla Lansang, MD
Assistant Professor, Division of Dermatology
University of Toronto
Toronto, ON

Jennifer Cather, MD
Dermatologist, Medical Director of Mindful Dermatology
Dallas, TX

Program Description

Interactive, case-based, and rich in provocative discussions, this dynamic symposium covers some of the hottest topics in psoriasis care. A panel of experts will explore how modern biologics with different targeted pathways are raising our expectations for speed of response and skin clearance. Optimal approaches to managing psoriasis in hard-to-treat areas, especially the genitals, will be presented and discussed. The symposium also features a leading US clinician researcher, Dr. Jennifer Cather, who will share practical tips on bringing mindfulness to patient interactions with the goal of establishing respect, building trust, and empowering patients.

Don’t stow your mobile! This accredited symposium uses an on-line platform that participants can access in order to test their pre- and post-symposium knowledge, and, throughout case presentations, participate in group polling about treatment choices. Participants can also answer self-reflection questions, establishing actions they will take over the next 3-6 months to bridge the gaps in their practice they identified through the symposium.

Learning Objectives

Upon completion of this program, participants will be able to:

  • Summarize the latest clinical evidence for new psoriasis treatments, including efficacy in hard-to-treat areas
  • Describe patients who may benefit from a change in therapy aimed at achieving greater skin clearance
  • Adopt approaches to interacting with patients to improve overall care

Integrating new data and technology to improve hidradenitis suppurativa (hs) standard of care


Jaggi Rao, MD, FRCPC
Dermatologist, Edmonton

Afsaneh Alavi, MD, MSc, FRCPC
Dermatologist, Toronto

Ralph George, MD, FRCSC
General Surgeon, Toronto

Program Description

It is the goal of this symposium to educate participants on the urgent need to quickly diagnose and treat HS. How? By exposing them to the latest technologies; expounding on the optimal therapeutic options; presenting the most recent data and guidelines; and explaining the medical and surgical benefits of co-management.

Key new information on HS treatment will be reviewed:

  • First North American HS Guidelines
    • Which treatments should be used, in which order, and for how long?
    • Aligned with CDA’s three-year strategic plan to increase advocacy and position statements, including clinical practice guidelines
  • First and only completed phase III trials in HS
    • What do we know about maintenance of response and long-term safety of approved treatment for HS?
    • Newly published three-year results from the open-label extension of the PIONEER I and II studies

This interactive and immersive session will equip dermatologists with practical tools, understanding of optimal therapeutic options and knowledge of cutting-edge technology to accelerate diagnosis, facilitate HS management, optimize treatment, and foster a collaborative network, all with the goal of improving patient care.

Learning Objectives

Following this educational session, participants will recognize and translate into practice their acquired learning to:

  • Select optimal therapeutic options for HS patients according to new guidelines and latest data in order to improve patient outcomes
  • Explain the medical and surgical benefits of co-management and implement a co-management network
  • Utilize new technology to improve the diagnosis and standard of HS care

Challenges in planning and managing pregnancy and breastfeeding with psoriasis patients


Melinda Gooderham, MD, MSc, FRCPC
Perla Lansang, MD, FRCPC

Program Description

This one-hour accredited symposium will explore the patient journey of women of child-bearing age (WoCBA) who suffer from psoriasis. This includes from the initial diagnosis, family planning discussions, pregnancy and the postpartum period. Recent data available regarding the use of biologics during pregnancy and breastfeeding will be presented. This interactive symposium will feature case studies on differing treatment strategies during pregnancy and breastfeeding; will utilize polling to gauge audience opinion; and offer the opportunity for participants to ask questions.

Learning Objectives

At the end of this session, participants will be able to:

  • Evaluate the management approach for women diagnosed with psoriasis and of child-bearing age
  • Assess current treatment strategies used for patients who are pregnant or breastfeeding
  • Determine the risk/benefit balance between safety and disease control, using a series of case studies as a reference

Dermoscopy update and interactive Quiz

Speakers and Chair

Joël Claveau, dermatologist at the Melanoma and Skin Cancer Clinic, CHU de Québec, Hôtel-Dieu de Québec, Laval University

Program Description

Introduction and presentation of the session

15 min. Brief review of recent literature: dermoscope models, standardization of terminology, general approach, various vascular patterns, dermoscopy of special sites (face, scalp, acral skin, nails), benign nevi patterns, melanoma specific structures.

45 min. Interactive quiz with the presentation of multiple illustrative cases with clinical and dermoscopic images. Participants will be invited to vote for each of the cases and the right answers will be presented and explained. A large variety of benign and malignant, melanocytic and non-melanocytic tumors will be presented.

Learning Objectives

At the end of this session, participants will be able to:

  1. Identify the main dermoscopic criteria and algorithms and discover new dermoscopic signs
  2. Recognize benign and malignant pigmented and non pigmented lesions
  3. Recognize the main vascular patterns to help diagnose various skin tumors
  4. Test their knowledge of dermoscopy

APPlying novel technologies and therapies to optimize psoriasis management


Kirk Barber, MD, FRCPC
Kim Papp, MD, PhD, FRCPC, FAAD
Andrew Au

Program Description 

“Only digital health can bring healthcare into the 21st century and make patients the point-of-care. We prepare everyone in healthcare for the adoption of innovative, disruptive and smart technologies while keeping the human touch.”   Dr. Bertalan Meskó, The Medical Futurist Institute

Many Canadian dermatologists face a delicate balancing act:  at the same time that the demands on their time are growing, complex conditions such as psoriasis, with its multiple treatment options and many co-morbidities, are more challenging to manage.  Trying to juggle these time constraints with patients who are eager for better outcomes and treatment has many practitioners looking for more efficient solutions that will help them focus their efforts where they are able to maximize their expertise.

Yet despite these challenges, there is cause for optimism, even excitement, with emerging treatments that can better ameliorate disease pathogenesis and progression, andinnovative tech that can help dermatologists manage their patients’ expectations, reduce their social and psychological stigma and promote adherence. And being able to better manage their time, while at the same time enhancing patient outcomes, brings the equilibrium most practitioners are hoping to achieve.

But will patients be motivated to use apps? Will HCPs embrace them? Will they save time? Will they improve outcomes? How will this apply to dermatology?  Many tech health experts believe that digital health in dermatology practice will continue to grow as success is seen in other therapeutic fields. The future is friendly!

Learning Objectives

After participating in this presentation, audience members will be able to:

  • Summarize and discuss the treatment issues, therapeutic options and technical solutions across the spectrum of psoriasis and its comorbidities
  • Demonstrate and apply this knowledge to peers & patients
  • Formulate and integrate this new knowledge into their practice


Starting from Scratch: The Atopic March from Adolescence to Adulthood


Session Chair and Dermatologist: Dr. Kirk Barber
Pediatric Dermatologist and Allergist: Dr. Jim Bergman
Respirologist: Dr. Mark Fitzgerald

Program Description

Atopic dermatitis (AD) is a chronic inflammatory disease that comprises one of the first manifestations of the atopic march. Join Dr. Kirk Barber and a multidisciplinary panel of clinical experts as we explore the atopic diathesis, and scratch below the surface for a close-up on the management of atopic disease for dermatologists.

Topics will uncover the atopic patient journey from adolescence to adulthood, ranging from early manifestations of atopic dermatitis to allergic airway disease, including allergic rhinitis and asthma, to food allergy, and will include a review of updated Canadian clinical guidance on the assessment and management of AD in adults.

Learning Objectives

By the end of this session, participants will:

  • Understand the pathophysiology of the atopic march and its associated diseases
  • Gain clinical insights on the recognition and management of atopic diseases in both the adolescent and adult populations
  • Explore complex cases in atopic disease with leading Canadian specialists in dermatology, pediatrics, allergy, and respirology, with a focus on conditions relevant to the dermatologist
Print Symposia Details